China Journal of Chinese Materia Medica · 2016 · 10 citations · 0 references
Natural SciencesMedicinal ChemistryPharmacologyMycologyOrganic ChemistryStructure-activity RelationshipsHeterocyclic ChemistryMarine Natural ProductsMedicinal Plant KnowledgeStructure-activity Relationship AnalysisActive Compound IsolationBioactive Compounds From Marine FungiBioactive ConstituentsChemical PropertiesColumn ChromatographyMedicinal Plant ResourcesPharmacological ScreeningPhysical Properties
Ten compounds were isolated from Mylabris phalerata by using preparative HPLC and column chromatography over MCI gel. On the basis of physical-chemical properties, NMR and MS data analysis, the compounds were identified as 5'-[(1 R,2 R,3 S,6R)-1-hydroxymethyl-2-methyl-3,6-epoxycyclohexane-1,2-dicarboximide]- ethyl-2'-methyl-2'-butenoate (1),cantharidin (2), cyclo-(L-Pro-L-Ala) (3), cyclo-(R-Pro-R-Leu) (4), cyclo-(S-Pro-R-Leu) (5), cyclo-(D-Pro-L-Tyr) (6), indole-3-aldehyde (7), 3-indoleacetic acid (8), valerolactam (9), and 4-hydroxyphthalid (10).Compound 1 was a new compound, and compounds 2-10 were obtained from this genus for the first time. Compounds 1-9 were subjected to cytotoxic activity on HCT-116, HepG2, BGC-823, NCI-H1650, A2780 cell lines, and only compound 2 showed inhibitory effect on all cancer cell lines.